Research ppj

Her digital health record began to reflect
not only her physical health - but
her lifestyle and environment data,
which are important factors in assessing
whether she is right for a trial.
Collectively, these insights fed back to the
clinicians involved in Elaine’s healthcare.
They helped to give context to how she
was feeling, and highlighted any trials
that would suit her.
As a parent, Elaine’s biggest worry is that
treatment be aggressive, and the side effects
will damage her ability to raise her
children.
She makes her clinican aware of these
priorities whilst reviewing her medical
and lifestyle records with her oncologist.
The oncologist desribes one particular a
trial highlighted by the TrialSeek software.
The trial highlighted by TrialSeek is for an
immmunotherapy drug named Bionoliav.
the drug belongs to a class of drugs called
checkpoint inhibitors, which “release the
brakes” on the immune system, allowing
a stronger attack against cancer.
84
The data collected by TrialSeek showed that
Elaine met all the criteria for the trial, and
as the drug works in a way that is less aggressive
than other treatments, was a good
match for her. She received a letter explaining
the trial in greater detail.